Organization Overview
Alternative names
abiraterone (zytiga) (1 trial)
acetylsalicylic acid (aspirin) (2 trials)
aflibercept (zaltrap) (1 trial)
aldesleukin (proleukin) (5 trials)
allogeneic hematopoietic stem cells (Hemacord) (8 trials)
amphotericin b (fungizone) (2 trials)
apalutamide (erleada) (1 trial)
asparaginase (elspar) (2 trials)
autologous bone marrow (6 trials)
autologous hematopoietic cell (1 trial)
bacille calmette-guerin (2 trials)
bevacizumab (avastin) (8 trials)
bexarotene (targretin) (1 trial)
bicalutamide (casodex) (9 trials)
binimetinib (mektovi) (2 trials)
bleomycin (blenoxane) (9 trials)
bortezomib (velcade) (3 trials)
capecitabine (xeloda) (7 trials)
carboplatin (paraplatin) (20 trials)
caspofungin (cancidas) (2 trials)
celecoxib (celebrex) (2 trials)
chlorambucil (Leukeran) (2 trials)
cisplatin (platinol) (58 trials)
cyclophosphamide (cytoxan) (26 trials)
cytarabine (cytosar-u) (19 trials)
daunorubicin (cerubidine) (7 trials)
decitabine (dacogen) (2 trials)
degarelix acetate (firmagon) (1 trial)
deoxycholic acid (kybella) (1 trial)
docetaxel (taxotere) (16 trials)
doxorubicin (Doxil) (35 trials)
durvalumab (imfinzi) (4 trials)
encorafenib (braftovi) (2 trials)
enzalutamide (xtandi) (1 trial)
epirubicin (ellence) (9 trials)
erlotinib (tarceva) (2 trials)
estradiol (progynon depot) (1 trial)
etoposide (vepesid) (26 trials)
exemestane (aromasin) (2 trials)
filgrastim (neupogen) (3 trials)
fludarabine (fludara) (2 trials)
fludeoxyglucose f-18 (3 trials)
fluorouracil (efudex) (39 trials)
flutamide (eulexin) (3 trials)
fulvestrant (faslodex) (1 trial)
gemcitabine (gemzar) (16 trials)
gemtuzumab ozogamicin (mylotarg) (4 trials)
goserelin (zoladex) (4 trials)
gp-100 peptide vaccine (1 trial)
irinotecan (Camptosar) (4 trials)
isotretinoin (accutane) (1 trial)
lanreotide (somatuline depot) (1 trial)
lenalidomide (revlimid) (1 trial)
leuprolide (lupron) (2 trials)
mechlorethamine (mustargen) (3 trials)
melphalan (alkeran) (4 trials)
mercaptopurine (purinethol) (3 trials)
methylprednisolone (medrol) (1 trial)
mitomycin (mutamycin) (5 trials)
mitoxantrone (novantrone) (8 trials)
na17.a2 peptide vaccine (1 trial)
naltrexone (revia) (10 trials)
oxaliplatin (eloxatin) (14 trials)
paclitaxel (taxol) (23 trials)
panitumumab (vectibix) (2 trials)
peripheral blood hematopoietic cell (11 trials)
piperacillin (pipracil) (1 trial)
prednisolone (hydeltra) (1 trial)
prednisone (meticorten) (11 trials)
procarbazine (matulane) (8 trials)
sargramostim (leukine) (17 trials)
tamoxifen (nolvadex) (4 trials)
telotristat ethyl (xermelo) (1 trial)
temozolomide (temodar) (23 trials)
tioguanine (Lanvis) (3 trials)
topotecan (hycamtin) (2 trials)
trabectedin (yondelis) (5 trials)
trastuzumab (herceptin) (7 trials)
triptorelin (Trelstar) (2 trials)
vancomycin (Vancocin) (1 trial)
vinblastine (velban) (12 trials)
vinorelbine (navelbine) (5 trials)
voriconazole (vfend) (1 trial)
afatinib (gilotrif) (3 trials)
amifostine (ethyol) (2 trials)
anastrozole (arimidex) (1 trial)
atezolizumab (tecentriq) (4 trials)
Bismuth Subcitrate Potassium (Pylera) (1 trial)
boronophenylalanine-fructose complex (2 trials)
brentuximab vedotin (adcetris) (1 trial)
cabazitaxel (jevtana kit) (1 trial)
cabozantinib (cometriq) (2 trials)
cetuximab (erbitux) (3 trials)
clarithromycin (biaxin) (1 trial)
clofarabine (clolar) (1 trial)
crizotinib (xalkori) (1 trial)
d1/3-mage-3-his fusion protein (1 trial)
depatuxizumab mafodotin (1 trial)
desvenlafaxine (pristiq) (1 trial)
escitalopram (lexapro) (1 trial)
human papillomavirus 16 e7 peptide (1 trial)
infliximab (remicade) (1 trial)
ipilimumab (yervoy) (3 trials)
lorlatinib (lorbrena) (1 trial)
metronidazole (flagyl) (1 trial)
mogamulizumab (poteligeo) (1 trial)
omeprazole (prilosec) (1 trial)
osimertinib (tagrisso) (1 trial)
palbociclib (ibrance) (2 trials)
pemetrexed (alimta) (3 trials)
Activated Protein C Resistance (Phase 2)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Clear Cell (Phase 2)
Adenomyoepithelioma (Phase 2)
Anemia (Phase 2)
Anus Neoplasms (Phase 3)
Aspergillosis (Phase 3)
Astrocytoma (Phase 1)
Bile Duct Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Breast Neoplasms (Phase 3)
Carcinoid Heart Disease (Phase 3)
Carcinoid Tumor (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Carcinoma, Transitional Cell (Phase 3)
Central Nervous System Neoplasms (Phase 3)
Cholangiocarcinoma (Phase 2)
Choriocarcinoma (Phase 3)
Cognition Disorders (Phase 3)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Dermatofibrosarcoma (Phase 2)
Endodermal Sinus Tumor (Phase 3)
Endometrial Neoplasms (Phase 3)
Esophageal Neoplasms (Phase 3)
Fallopian Tube Neoplasms (Phase 3)
Fever (Phase 3)
Gallbladder Neoplasms (Phase 2)
Gastrointestinal Stromal Tumors (Phase 3)
Germinoma (Phase 3)
Giant Cell Tumor of Bone (Phase 2)
Giant Cell Tumors (Phase 2)
Glioblastoma (Phase 3)
Glioma (Phase 3)
Gliosarcoma (Phase 3)
Granuloma, Plasma Cell (Phase 2)
Head and Neck Neoplasms (Phase 3)
Heart Diseases (Phase 3)
Hodgkin Disease (Phase 3)
Hot Flashes (Phase 3)
Infections (Phase 3)
Inflammatory Breast Neoplasms (Phase 3)
Intestinal Neoplasms (Phase 2)
Kidney Neoplasms (Phase 3)
Laryngeal Diseases (Phase 3)
Leiomyosarcoma (Phase 3)
Leukemia (Phase 4)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Promyelocytic, Acute (Phase 3)
Liposarcoma (Phase 3)
Liver Neoplasms (Phase 3)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 3)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Malignant Carcinoid Syndrome (Phase 3)
Mediastinal Neoplasms (Phase 3)
Medulloblastoma (Phase 2)
Melanoma (Phase 3)
Meningioma (Phase 2)
Mesothelioma (Phase 3)
Multiple Myeloma (Phase 3)
Mycoses (Phase 3)
Mycosis Fungoides (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Neoplasms, Second Primary (Phase 3)
Neoplasms, Squamous Cell (Phase 3)
Neoplastic Cells, Circulating (Phase 2)
Nervous System Neoplasms (Phase 3)
Neuroectodermal Tumors (Phase 2)
Neuroectodermal Tumors, Primitive (Phase 2)
Neuroendocrine Tumors (Phase 3)
Neutropenia (Phase 3)
Oligodendroglioma (Phase 3)
Osteosarcoma (Phase 3)
Ovarian Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 3)
Penile Neoplasms (Phase 2)
Pheochromocytoma (Phase 3)
Plasmacytoma (Phase 3)
Preleukemia (Phase 3)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 3)
Recurrence (Phase 3)
Rhabdomyosarcoma (Phase 2)
Rhabdomyosarcoma, Alveolar (Phase 2)
Salivary Gland Neoplasms (Phase 2)
Sarcoma (Phase 3)
Sarcoma, Alveolar Soft Part (Phase 2)
Sarcoma, Clear Cell (Phase 2)
Sarcoma, Ewing (Phase 2)
Sarcoma, Synovial (Phase 2)
Seminoma (Phase 3)
Serotonin Syndrome (Phase 3)
Sezary Syndrome (Phase 2)
Small Cell Lung Carcinoma (Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 3)
Syndrome (Phase 3)
Teratoma (Phase 3)
Thymoma (Phase 2)
Thymus Neoplasms (Phase 2)
Thyroid Diseases (Phase 2)
Thyroid Neoplasms (Phase 2)
Ulcer (Phase 3)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 3)
Vulvar Neoplasms (Phase 2)
